Hepcidin has a major role in the anemia of CKD and elevated hepcidin level is likely to contribute to the incidence and severity of anemia, thus agents that have an effect of lowering hepcidin or inhibiting its actions may be effective on correcting anemia of CKD (Coyne, 2011). The gene discussed is HAMP; the disease is anemia.